| Filed On | Filing |
|---|---|
| 26 Oct 2026 | 144 |
| 23 Oct 2026 |
Form 4: Carter Robert B, Director
Acquired 10 shares (Small Acquisition) ($2.36K) |
| 23 Oct 2026 |
Form 4: Samad Sam, Executive Vice President & CFO
Received 90 shares as a grant or award ($21.2K) |
| 23 Oct 2026 |
Form 4: Gregg Vicky B, Director
Received 63 shares as a grant or award ($14.9K) |
| 23 Oct 2026 |
Form 4: Kuppusamy Karthik, SVP, Clinical Solutions
Acquired 33 shares (Small Acquisition) ($7.79K) |
| 23 Oct 2026 |
Form 4: Lassiter Wright Iii, Director
Acquired 6 shares (Small Acquisition) ($1.42K) |
| 23 Oct 2026 |
Form 4: Plewman Patrick, SVP for Diagnostic Services
Acquired 41 shares (Small Acquisition) ($9.67K) |
| 23 Oct 2026 |
Form 4: Main Timothy L, Director
Acquired 18 shares (Small Acquisition) ($4.25K) |
| 23 Oct 2026 |
Form 4: Delaney Mark E, SVP & Chief Commercial Officer
Acquired 25 shares (Small Acquisition) ($5.9K) |
| 23 Oct 2026 | 10-Q |
| 22 Oct 2026 |
8-K: Other Events
On October 21, 2026, Quest Diagnostics Incorporated (the “Company”) learned of unauthorized access to its Quanum LSM system, which certain clients use to place test orders, receive and look up results. The Company promptly initiated its ... |
| 22 Oct 2026 |
8-K: Results of Operations and Financial Condition
SECAUCUS, N.J., October 22, 2026 - Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the third quarter ended September 30, 2026. |
| 06 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On October 6, 2026, Quest Diagnostics Incorporated (the “Company”) announced that Catherine T. Doherty will retire in July 2027. Until then, effective November 1, 2026, Ms. Doherty will transition to a new role as Executive Vice Presiden... |
| 02 Oct 2026 |
Form 4: Wentworth Timothy C, Director
Granted 135 Phantom Stock Units |
| 03 Sep 2026 |
Form 4: Davis J. E., Director
Sold 10,000 shares ($2.43M) |
| 01 Sep 2026 | 144 |
| 31 Aug 2026 |
Form 4: Prevoznik Michael E, SVP & General Counsel
Received 22,677 shares by exercise or conversion ($2.54M) · Sold 22,677 shares ($5.51M) · Gave 1,000 shares as a gift |
| 28 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 29 Jul 2026 |
Form 4: Delaney Mark E, SVP & Chief Commercial Officer
Sold 1,600 shares ($376K) |
Loading...
